Regentis Biomaterials strengthens cartilage-repair technology, VERAXA Biotech collaborates to enhance oncology pipeline with AI, and the American Heart Association launches a health tech competition. Fitness legend Monica Brant joins N1o1 Nitric Oxide as a product ambassador, while researchers identify a protein for targeted glioblastoma treatments. Nanox Imaging Ltd. signs UK reseller agreement for HealthOST AI bone solution, NanoViricides, Inc. prepares for Phase II trial of NV-387 Oral Gummies for Ebola treatment, and Cardio Diagnostics Holdings, Inc. launches in-house CLIA-certified laboratory. Helus Pharma(TM) appoints new executives, and SS Innovations International reports record revenue for Q2 with plans for FDA clearance and EU CE marking.